UK markets open in 3 hours 22 minutes

Redx Pharma Plc (REDX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
15.00+3.60 (+31.58%)
At close: 05:28PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 58.35M
Enterprise value 57.94M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.96
Price/book (mrq)17.39
Enterprise value/revenue 13.79
Enterprise value/EBITDA -1.93

Trading information

Stock price history

Beta (5Y monthly) -0.53
52-week change 3-53.85%
S&P500 52-week change 323.57%
52-week high 337.90
52-week low 30.00
50-day moving average 315.13
200-day moving average 321.75

Share statistics

Avg vol (3-month) 3966.38k
Avg vol (10-day) 3628.87k
Shares outstanding 5388.99M
Implied shares outstanding 6388.99M
Float 850.81M
% held by insiders 118.35%
% held by institutions 172.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-706.61%

Management effectiveness

Return on assets (ttm)-43.95%
Return on equity (ttm)-180.80%

Income statement

Revenue (ttm)4.2M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-81.70%
Gross profit (ttm)N/A
EBITDA -30.55M
Net income avi to common (ttm)-33.16M
Diluted EPS (ttm)-0.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.09M
Total cash per share (mrq)0.05
Total debt (mrq)17.68M
Total debt/equity (mrq)527.00%
Current ratio (mrq)1.11
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-34.75M
Levered free cash flow (ttm)-22.47M